The challenge
01Overcoming Legacy Limitations in Critical Infrastructure
The biotechnology leader faced significant challenges with their existing vulnerability management provider, including limited visibility, manual processes, and poor reporting ability, leading to time spent on building their own reports and manually tracking vulnerabilities. These limitations posed risks to intellectual property protection and regulatory compliance in a highly regulated industry.
- 01Inadequate visibility across diverse operating systems supporting corporate and research environments
- 02Manual vulnerability tracking causing delays in critical patch management prioritization
- 03Disconnected workflows between vulnerability management, GRC, and penetration testing results
- 04Inability to perform fleet-wide threat hunting across research and corporate networks with current solutions
